dr. choueiri on impact of cabosun results in renal cell carcinoma
Published 6 years ago • 236 plays • Length 0:52Download video MP4
Download video MP3
Similar videos
-
1:44
dr. choueiri on cabosun trial results in rcc
-
1:45
dr. choueiri on cabosun trial results for rcc
-
1:20
dr. choueiri on overall findings of cabosun trial for rcc
-
0:52
dr. choueiri on the role of cabozantinib in rcc
-
1:08
dr. choueiri on the biology of the cabosun trial for rcc
-
1:47
dr. choueiri on the impact of the javelin renal 101 findings in rcc
-
0:41
dr. toni choueiri on cabozantinib and nivolumab combination in kidney cancer
-
1:06
dr. choueiri on fda approval of cabozantinib for rcc
-
1:35
dr. toni choueiri on cabozantinib versus everolimus in renal cell carcinoma
-
0:45
dr. choueiri on fda approval of lenvatinib/everolimus in rcc
-
0:59
dr. choueiri on the impact of the covid-19 pandemic on treatment in rcc
-
5:08
cabosun trial of upfront cabozantinib in metastatic rcc
-
1:52
dr. choueiri on using immunotherapy to treat rcc
-
2:03
dr. choueiri on savolitinib in papillary renal cell cancer
-
1:37
dr. choueiri on synergy between immunotherapy and vegf inhibitors in rcc
-
6:26
esmo 2016: press brief on results of cabosun trial cabozantinib compared to sunitinib in rcc
-
1:51
dr. choueiri on ongoing trials of immunotherapy in rcc
-
1:02
dr. choueiri on the research with immunotherapy in rcc
-
1:06
dr. choueiri on atezolizumab plus bevacizumab in non–clear cell rcc